Blueflame Labs designs validated enterprise ERP architectures that orchestrate Clinical Trial Material (CTM) manufacturing, cold-chain distribution, and investigational drug accountability. We enable clinical-stage biopharma leaders to maintain absolute regulatory compliance with FDA 21 CFR Part 11 and cGMP.
We design, configure, and validate enterprise ERP systems following GAMP 5 methodologies, providing electronic signatures, tamper-evident audit trails, and automated change-control governance, while delivering verified regulatory compliance, continuous telemetry monitoring, automated testing, and scalable enterprise cloud reliability.
Our developers build bidirectional API bridges connecting central ERP inventory with clinical site Interactive Response Technologies to automate patient-specific investigational drug kit dispensations, while delivering verified regulatory compliance, robust data security, automated testing, and scalable enterprise cloud reliability.
We integrate real-time IoT temperature and GPS sensors into the ERP, tracking vapor-phase liquid nitrogen (-150C) and dry ice shipping containers with automated temperature excursion alerts, while delivering verified regulatory compliance, robust data security, and scalable cloud reliability.
We engineer automated drug accountability modules that reconcile dispensed, unused, and returned investigational vials across all clinical trial sites, preparing audit-ready regulatory reports, while delivering verified regulatory compliance, robust data security, automated testing, and scalable enterprise cloud reliability.
Delivered with complete Computerized System Validation (CSV) protocols, IQ/OQ/PQ scripts, and trace matrices, ensuring continuous 99.99% system availability, automated operational telemetry, robust data protection, and verified compliance.
Predictive inventory replenishment algorithms prevent investigational drug shortages across global trial centers, ensuring continuous 99.99% system availability, automated operational telemetry, robust data protection, and verified regulatory compliance.
Continuous IoT temperature sensor integration guarantees the biological integrity of delicate gene therapy vials, ensuring continuous 99.99% system availability, automated operational telemetry, and verified enterprise regulatory compliance.
Specialized consultants with deep experience in FDA cGMP, EMA, and GCP clinical manufacturing guidelines, ensuring continuous 99.99% system availability, automated operational telemetry, and verified enterprise regulatory compliance.
Managing plasmid DNA synthesis, mRNA formulation, lipid nanoparticles, and viral vector batch records, delivering real-time data streaming, automated workflow orchestration, and verified institutional compliance reporting across enterprise systems.
Tracking microbubble ultrasound delivery agents, specialized acoustic emitters, and therapeutic drug payloads, delivering real-time data streaming, automated workflow orchestration, high-throughput message processing, and verified compliance reporting across systems.
Coordinating autologous and allogeneic cell collections, cryogenic preservation, and infusion logistics, delivering real-time data streaming, automated workflow orchestration, high-throughput message processing, and verified institutional compliance reporting across enterprise systems.
Blueflame Labs deployed a validated 21 CFR Part 11 ERP system for our clinical gene therapy trials. We manage cryogenic drug distribution across 45 global hospital sites with zero temperature excursions or stockouts.
Partnering with Blueflame Labs transformed our systems architecture and development velocity, while maintaining 99.99% high availability, continuous scalability, and strict regulatory compliance across all our mission-critical production with guaranteed endpoints.
The technical expertise and architectural guidance provided by Blueflame Labs were instrumental to our success, while maintaining 99.99% high availability, continuous scalability, and strict regulatory compliance across all our mission-critical production endpoints.